ニュース
Hospital groups are celebrating a federal judge’s initial ruling against pharmaceutical makers who contended a government ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big ...
Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...
European pharma leaders push for higher drug prices to boost global competitiveness. 2. CEOs warn EU may lose out on ...
President Trump said that prescription benefit managers, or PBMs, would be left out of a new government initiative aimed at ...
Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...
An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
President Trump issues an executive order that will push drugmakers to offer prescription drugs to U.S. cash-pay consumers at lower prices.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する